Executive Director at Institut Pasteur Korea (IPK) with +15 years of experience working on strategies to prevent and cure viral diseases (e.g. Hepatitis (B, C, D, E), Zika, Ebola, HIV, MERS-CoV etc.).
Established the Applied Molecular Virology Laboratory at IPK in 2007, and since then responsible for strategic leadership, translational research, innovation, drug discovery and development, basic science, external collaborations, funding, and managing of diverse teams of up to 50 members.
Worked on the development of antiviral drugs, evaluated virucidal activities of disinfectants on Hepatitis and Ebola viruses, and assessed virus inactivation devices for blood products in collaboration with Red Cross. Alongside the US NIH, working on drug repurposing strategies for Ebola disease. Currently, also a Professor at the University of Science and Technology (UST) in South Korea teaching and mentoring trainees, Master, and Ph.D. students. 36 publications, 8 provisional patents and 1 full patent (PCT).